ロード中...

The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel

BACKGROUND: Different platelet function tests can be used to evaluate the degree of achieved platelet inhibition in patients treated with clopidogrel. The presence of CYP 2C19*2 polymorphism can reduce the formation of the active metabolite of clopidogrel, resulting in less platelet inhibition. PATI...

詳細記述

保存先:
書誌詳細
主要な著者: Pettersen, Alf-Aage R, Arnesen, Harald, Opstad, Trine B, Seljeflot, Ingebjorg
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2011
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3071307/
https://ncbi.nlm.nih.gov/pubmed/21426546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-9560-9-4
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!